SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Trial ID or NCT#
NCT04033367
Status
NOT RECRUITING
Purpose
Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult participants with moderate to severe atopic dermatitis (AD). Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation. To continue to assess the safety and tolerability throughout the study.
Official Title
A Randomized Double-blind, Placebo-controlled Study Evaluating the Effect of Dupilumab on Sleep in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Albert Sean Chiou
Dermatologist,
Cutaneous oncology specialist
Clinical Associate Professor, Dermatology
Justin M Ko, MD, MBA
Dermatologist,
Melanoma specialist,
Cutaneous oncology specialist,
Hair loss specialist,
Psoriasis specialist
Clinical Professor, Dermatology
View on ClinicalTrials.gov
